Westminster, CO – According to filings with the U.S. Securities and Exchange Commission, Next Frontier Biosciences is raising $1,199,999.00 in new funding. Sources indicate as part of senior management President, Marc Graboyes played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Next Frontier Biosciences

Next Frontier Biosciences (NFB) is a Colorado-based biotech company developing best-in-class purified cannabinoid products for the treatment of chronic pain and other serious medical conditions. Bringing advanced formulation sciences to the world of medical cannabis. Building premium brand targeting multi-billion dollar medical cannabis and pain management markets. Commercially ready now with products available in both Colorado and California, and leveraging proprietary formulations and premium brand strategy to become global leader in medical cannabis. At Next Frontier Biosciences, we believe that scientific formulation is the key to developing safer and more effective cannabinoid treatments.

To learn more about Next Frontier Biosciences, visit http://nextfrontierbio.com/

Contact:
Marc Graboyes, President
303-550-3133
marc@nextfrontierbio.com
https://www.linkedin.com/in/marcgraboyes/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved